London (1)

Corneal Diseases (1)

Descemet's Membrane Disorder (1)

FECD3 (1)

Fuchs Endothelial Corneal Dystrophy (1)

LRS (1)

Withdrawn (1)

phase 1 (1)

ProQR Therapeutics (1)

qr-504a (1)

drug (1)

Industry (1)

Interventional (1)

descemet's membrane disorder

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Withdrawn

London, United Kingdom

Moorfields Eye Hospital, NIHR Clinical Research Facility

May 5, 2022